Clinical Trial Update: Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids [Phase 2]

View source ↗

Summary

A Phase 2 pharmacokinetic and safety study of oral lofexidine in neonates experiencing opioid withdrawal due to intrauterine opioid exposure; the trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome
• Opioid Withdrawal Disorder

Drugs mentioned

• LOFEXIDINE (LOFEXIDINE)

Snippet

Sponsor: BioCorRx Pharmaceuticals Inc | Conditions: Opioid Withdrawal (Disorder) | Phase 2 | Status: ACTIVE_NOT_RECRUITING